Zhang Y, Tian XL, Li JQ, Wu DS, Li Q, Chen B. Mitochondrial dysfunction affects hepatic immune and metabolic remodeling in patients with hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol 2024; 30(8): 881-900 [PMID: 38516248 DOI: 10.3748/wjg.v30.i8.881]
Corresponding Author of This Article
Bin Chen, PhD, Chief Physician, Department of Hepatology, Institute of Hepatology, The First Affiliated Hospital of Hunan University of Chinese Medicine, No. 95 Middle Shaoshan Road, Yuhua District, Changsha 410021, Hunan Province, China. chenbin0410@126.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Observational Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Zhang Y, Tian XL, Li JQ, Wu DS, Li Q, Chen B. Mitochondrial dysfunction affects hepatic immune and metabolic remodeling in patients with hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol 2024; 30(8): 881-900 [PMID: 38516248 DOI: 10.3748/wjg.v30.i8.881]
Yu Zhang, Xiao-Ling Tian, Bin Chen, Department of Hepatology, Institute of Hepatology, The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha 410021, Hunan Province, China
Jie-Qun Li, Qiang Li, Department of Liver Transplant, Transplant Medical Research Center, The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan Province, China
Dong-Sheng Wu, Department of Surgery, The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha 410021, Hunan Province, China
Author contributions: Zhang Y and Tian XL performed experiments, analysed data and wrote the paper; Wu DS and Li Q performed experiments and analysed data; Li JQ and Chen B designed experiments, performed experiments and edited the paper.
Supported bythe Domestic First-class Construction Disciplines of the Hunan University of Chinese Medicine; Postgraduate Research Innovation Program of Hunan Province, No. CX20220771; and Clinical MedTech Innovation Project of Hunan Province, No. 2021SK51415.
Institutional review board statement: The study protocol was approved by the Ethics Committee of the First Hospital of Hunan University of Chinese Medicine (No. HN-LL-SWST-15), and written informed consent was obtained from all participants.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: The authors declare no conflicts of interest that pertain to this work.
Data sharing statement: All data generated or analyzed during this study are included in this published article.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Corresponding author: Bin Chen, PhD, Chief Physician, Department of Hepatology, Institute of Hepatology, The First Affiliated Hospital of Hunan University of Chinese Medicine, No. 95 Middle Shaoshan Road, Yuhua District, Changsha 410021, Hunan Province, China. chenbin0410@126.com
Received: October 8, 2023 Peer-review started: October 8, 2023 First decision: December 8, 2023 Revised: December 15, 2023 Accepted: January 23, 2024 Article in press: January 23, 2024 Published online: February 28, 2024 Processing time: 141 Days and 10.7 Hours
Core Tip
Core Tip: Our data were obtained from liver of patients with hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF), whose mitochondrial function, metabolites, and immune microenvironment were less susceptible to any confounding factors caused by other failing organs. Widely infiltrating macrophages were originated from peripheral circulating monocytes in the liver of patients with HBV-ACLF. Mitochondrial oxidative phosphorylation was decreased, and anaerobic glycolysis was enhanced in patients with HBV-ACLF. Liver of patients made greater use of the extra-mitochondrial glycolytic pathway for providing energy. Bioenergetic alteration driven by hypoxia and mitochondrial dysfunction contribute to hepatic immune and metabolic remodeling, may leading to organ failure and poor clinical prognosis in patients with advanced HBV-ACLF.
